"Hepacivirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
| Descriptor ID |
D016174
|
| MeSH Number(s) |
B04.450.410 B04.820.250.475
|
| Concept/Terms |
Hepacivirus- Hepacivirus
- Hepaciviruses
- Hepatitis C-Like Viruses
- Hepatitis C Like Viruses
- Hepatitis C-Like Virus
|
Below are MeSH descriptors whose meaning is more general than "Hepacivirus".
Below are MeSH descriptors whose meaning is more specific than "Hepacivirus".
This graph shows the total number of publications written about "Hepacivirus" by people in this website by year, and whether "Hepacivirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 3 | 4 |
| 1999 | 2 | 2 | 4 |
| 2000 | 2 | 3 | 5 |
| 2001 | 1 | 2 | 3 |
| 2002 | 3 | 1 | 4 |
| 2003 | 2 | 2 | 4 |
| 2004 | 7 | 1 | 8 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 4 | 1 | 5 |
| 2010 | 5 | 4 | 9 |
| 2011 | 7 | 5 | 12 |
| 2012 | 7 | 2 | 9 |
| 2013 | 4 | 2 | 6 |
| 2014 | 6 | 2 | 8 |
| 2015 | 5 | 2 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 2 | 4 | 6 |
| 2018 | 3 | 4 | 7 |
| 2019 | 4 | 7 | 11 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepacivirus" by people in Profiles.
-
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023 02; 112:103930.
-
HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago. J Public Health (Oxf). 2022 Dec 01; 44(4):891-899.
-
Transcriptional Inhibition of MicroRNA miR-122 by Small Molecules Reduces Hepatitis C Virus Replication in Liver Cells. J Med Chem. 2022 12 22; 65(24):16338-16352.
-
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer. 2022 10 01; 128(19):3470-3478.
-
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. PLoS One. 2022; 17(3):e0264983.
-
Screening for Hepatitis C Virus. JAMA. 2021 Jul 27; 326(4):348-349.
-
The Impact of Treatment Delay on Hepatitis C Liver Transplant Outcomes. J Pharm Pract. 2023 Apr; 36(2):264-270.
-
Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care. Liver Transpl. 2021 04; 27(4):548-557.
-
Three-Dimensional Cell Culture Systems for Studying Hepatitis C Virus. Viruses. 2021 01 30; 13(2).
-
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice. Sci Adv. 2020 11; 6(45).